Humalog®

This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.

INSULIN LISPRO MIX75/25 Versus HUMALOG® MIX75/25

When transitioning from Humalog® Mix75/25™ to Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25™ KwikPen® (100 units/mL), no dose conversion is needed.

Detailed Information

Do not perform dose conversion when transitioning to the generic LM75/25 3-mL Pen from Humalog Mix75/25 3-mL Pen.

For example, if a patient is transitioning from 20 units of Humalog Mix75/25, the patient would administer 20 units of generic LM75/25.

Generic LM75/25 is identical to Humalog Mix75/25 in terms of

  • active ingredients

  • inactive ingredients

  • manufacturing, and  

  • 3-mL Pen packaging.

Generic LM75/25 3-mL Pen has a unique NDC number, label, and package insert.

Enclosed Prescribing Information

HUMALOG® Mix75/25™ (insulin lispro protamine and insulin lispro injectable suspension), for subcutaneous use, Lilly

INSULIN LISPRO PROTAMINE AND INSULIN LISPRO INJECTABLE SUSPENSION MIX75/25™, for subcutaneous use, Lilly

Glossary

Generic = authorized generic

Humalog Mix75/25 = Humalog® Mix75/25 (insulin lispro protamine and insulin lispro injectable suspension)

Lilly = Eli Lilly and Company

LM75/25 = Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25™

NDC = National Drug Code

Pen = KwikPen®

Date of Last Review: February 23, 2020

Contact Lilly

Call Us

If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.

Available Mon - Fri, 8am - 7pm ET

Or you can

Ask us a question Chat with us

Submit a Request

Visit Us @LillyMedical